glutathione disulfide has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade-da-Costa, BLDS; Augusto, RL; Cardoso, PRG; da Penha Gonçalves, LV; da Silva-Júnior, JC; de Albuquerque Rego, GN; de Souza Andrade, D; de Souza, IA; de Souza, RF; Dos Santos, ML; Medeiros-Linard, CFB; Mendonça, IP; Moreno, GMM; Peixoto, CA; Pereira, DD; Pereira, MC | 1 |
| Chen, CF; Ho, LT; Lin, AM | 1 |
| Grünblatt, E; Mandel, S; Maor, G; Youdim, MB | 1 |
3 other study(ies) available for glutathione disulfide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Purified anacardic acids exert multiple neuroprotective effects in pesticide model of Parkinson's disease: in vivo and in silico analysis.
Topics: Anacardic Acids; Animals; Computer Simulation; Corpus Striatum; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Disulfide; Humans; Interleukin-1beta; Lipid Peroxidation; Matrix Metalloproteinase 9; Mice; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Tyrosine 3-Monooxygenase | 2020 |
Neuroprotective effect of intermittent hypoxia on iron-induced oxidative injury in rat brain.
Topics: Animals; Atmosphere Exposure Chambers; Brain; Buthionine Sulfoximine; Catalase; Disease Models, Animal; Drug Administration Routes; Female; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Hypoxia; Iron; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Substantia Nigra; Superoxide Dismutase | 2002 |
Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Binding, Competitive; Catecholamines; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Glutathione; Glutathione Disulfide; Immunohistochemistry; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Stereoisomerism; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |